Gene amplifications detected by array CGH
| Gene | Hormone-sensitive tumors | Hormone-escaped tumors | P | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Amplifications | Tumors | Percentage | Amplifications | Tumors | Percentage | ||||||
| MET | 3 | 16 | 18.75 | 0 | 19 | 0.00 | 0.250 | ||||
| PTPN1 | 2 | 18 | 11.11 | 0 | 18 | 0.00 | 0.500 | ||||
| KRAS2 | 4 | 19 | 21.05 | 1 | 18 | 5.56 | 0.375 | ||||
| HER2 | 3 | 19 | 15.79 | 1 | 18 | 5.56 | 1.000 | ||||
| MYCN | 3 | 18 | 16.67 | 2 | 18 | 11.11 | 1.000 | ||||
| D17S1670 | 1 | 19 | 5.26 | 2 | 18 | 11.11 | 1.000 | ||||
| CBFA2 | 3 | 18 | 16.67 | 3 | 19 | 15.79 | 1.000 | ||||
| IGFR1 | 2 | 19 | 10.53 | 3 | 19 | 15.79 | 1.000 | ||||
| TERC | 1 | 18 | 5.56 | 3 | 19 | 15.79 | 0.500 | ||||
| HRAS | 1 | 19 | 5.26 | 3 | 19 | 15.79 | 0.500 | ||||
| MYC | 0 | 18 | 0.00 | 3 | 19 | 15.79 | 0.250 | ||||
| CSE1L | 2 | 15 | 13.33 | 3 | 18 | 16.67 | 0.500 | ||||
| JUNB | 1 | 18 | 5.56 | 3 | 18 | 16.67 | 0.500 | ||||
| RAF1 | 1 | 19 | 5.26 | 3 | 18 | 16.67 | 0.500 | ||||
| FGFR1 | 0 | 18 | 0.00 | 3 | 17 | 17.65 | 0.250 | ||||
| MYBL2 | 2 | 19 | 10.53 | 4 | 19 | 21.05 | 0.625 | ||||
| GARP | 1 | 17 | 5.88 | 4 | 18 | 22.22 | 0.250 | ||||
| CTSB | 5 | 17 | 29.41 | 6 | 19 | 31.58 | 1.000 | ||||
| ESR | 4 | 18 | 22.22 | 6 | 19 | 31.58 | 0.625 | ||||
| STK15 | 5 | 18 | 27.78 | 6 | 18 | 33.33 | 1.000 | ||||
| SAS/CDK4 | 3 | 18 | 16.67 | 6 | 18 | 33.33 | 0.250 | ||||
| FGR(Src-2) | 0 | 19 | 0.00 | 7 | 19 | 36.84 | 0.016 | ||||
| LAMC2 | 5 | 18 | 27.78 | 7 | 18 | 38.89 | 0.500 | ||||
| PGY1 | 3 | 15 | 20.00 | 7 | 18 | 38.89 | 0.375 | ||||
| MYB | 3 | 19 | 15.79 | 8 | 19 | 42.11 | 0.063 | ||||
| FGFR2 | 9 | 18 | 50.00 | 8 | 18 | 44.44 | 1.000 | ||||
| NRAS | 9 | 19 | 47.37 | 9 | 19 | 47.37 | 1.000 | ||||
| MYCL1 | 4 | 18 | 22.22 | 9 | 19 | 47.37 | 0.125 | ||||
| PI3K | 7 | 18 | 38.89 | 9 | 18 | 50.00 | 0.375 | ||||
| AR | 12 | 19 | 63.16 | 10 | 15 | 67.23 | 1.000 | ||||